Influence of a Bitter Compound and Bittermasking Compound on Gastric pH

February 19, 2015 updated by: Univ.-Prof. Dr. Veronika Somoza, University of Vienna

Effect of Caffeine With and Without a Bitter Masking Compound on Gastric pH, Taking Into Account the Effect on Satiety Hormones in Blood Plasma and on Food Intake

The purpose of this study is to elucidate whether bitter taste induced by the bitter compound caffeine and the reduction of bitter taste by addition of the bitter masking compound Homoeriodictyol sodium salt (HED) influence gastric acid secretion, subjective feelings of hunger, ad libitum food intake and satiating hormones in healthy volunteers.

Study Overview

Detailed Description

The influence of 125 mL water, 150 mg caffeine/125 mL water, 30 mg HED/125 mL water or the combination of 150 mg caffeine + 30 mg HED/125 mL water on the gastric pH on different test days was investigated. Prior to the intervention, the trial subjects had to fast from food and liquid for 10 h, except for 200 mL of tap water that were allowed during this time period. During the experiment, the subjects remained in a supine left-sided position.

For the non-invasive measurement of the gastric pH, the Heidelberg Detection System (Heidelberg Medical Inc., USA) was used which has been successfully used in our working group.

This system consists of a pH-sensitive capsule (called a Heidelberg capsule), with a length of 2 cm, that has to be swallowed and contains a miniature radio transmitter. This system allows the detection of the actual gastric pH of the volunteer over a specific time period [Liszt et al 2012, Rubach et al. 2014].

Prior to each test, Heidelberg capsules were activated for 5 min in a 0.9% sterile NaCl solution and calibrated using two calibration points, pH 1 and 7. Afterward, the subjects swallowed the capsule lay down on the left side. The capsule sends a signal to a transceiver, which has to be placed on the abdomen of the volunteer. The transceiver sends the signal to the recorder connected to a computer. The data can be collected and shown as a gastrogram on the computer screen, where the pH is drawn over time. When the intragastric pH was constant between pH 0.5 and 2.5 for at least 3 min, the capsule was considered to be in the stomach. Afterward, each trial started with the administration of 5 mL of a saturated sodium bicarbonate solution (NaHCO3). This alkaline challenge triggers a rise in gastric pH between around pH 6 to 7 and subsequently leads to the secretion of stomach acid by the parietal cells. The test solutions were administered 5 minutes after or 30 min before the alkaline challenge.

Reacidification time as well as the time until start of the reacidification has been analyzed.

Ratings of hunger were assessed before and after each gastric pH measurement by means of visual analog scales (VAS). Before and after each intervention blood samples were drawn to quantify satiety hormones (ghrelin, PYY, GLP-1, serotonin). Ad libitum energy and macronutrient intakes from a standardized breakfast served after each treatment were calculated.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Vienna, Austria, 1090
        • Christian Doppler Laboratory for Bioactive Aroma Compounds

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • good general state of health
  • sensorically untrained
  • BMI: 19 - 26 kg/m2

Exclusion Criteria:

  • gastro-intestinal disease or discomfort,
  • metabolic diseases,
  • H.pylori infection,
  • smoking,
  • increased sensibility towards caffeine,
  • intake of antibiotics in the last 2 months,
  • medication except for oral contraceptives,
  • drug- or alcohol-abuse,
  • heart disease, high blood pressure,
  • pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Water
125 mL water are administered during or before gastric pH measurement
Control
Experimental: Caffeine
150 mg Caffeine and 125 mL water are administered during or before gastric pH measurement
Experimental: Caffeine + homoeriodictyol sodium salt
150 mg Caffeine + 30 mg homoeriodictyol sodium salt and 125 mL water are administered during or before gastric pH measurement
Experimental: homoeriodictyol sodium salt
30 mg homoeriodictyol sodium salt and 125 mL water are administered during the gastric pH measurement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Change of the intragastral pH determined by the Heidelberg Detection system
Time Frame: recorded over a time period from 1 - 60 min
recorded over a time period from 1 - 60 min

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of plasma levels of Serotonin, Ghrelin, PYY and GLP-1
Time Frame: Plasma are taken at two time points before and after the gastric pH measurement during a time period between 15 - 60 min
higher plasma levels of serotonin, PYY and GLP-1 are a satiety signal while higher levels of Ghrelin, Hunger-stimulating hormone, indicate appetite
Plasma are taken at two time points before and after the gastric pH measurement during a time period between 15 - 60 min
Food intake
Time Frame: after the gastric pH measurement on each testing day the subjects are served an ad libitum breakfast, and they have an open time frame how long they want to eat, max. 1 hour is anticipated
A weighed standard breakfast will be served and ad libitum energy intake will be assessed by weighing the left overs of the breakfast and analyzed by nutrient data base. Total caloric intake [kcal], as well as the total carbohydrate [g], protein [g] and fat [g] intake will be analyzed.
after the gastric pH measurement on each testing day the subjects are served an ad libitum breakfast, and they have an open time frame how long they want to eat, max. 1 hour is anticipated
subjective feelings of hunger are recorded by means of visual analog scales (VAS)
Time Frame: subjects are asked to fill the VAS out immediately before and after the gastric pH measurement, max. 2 min is anticipated
The volunteers have to make a sign on a 10 cm long scale (visual analog scale), ranging from 0 (not hungry) to 10 (very hungry). The volunteer can make the sign at any point of the scale and we will measure the distance from the beginning until the sign [cm].
subjects are asked to fill the VAS out immediately before and after the gastric pH measurement, max. 2 min is anticipated

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Veronika Somoza, Prof. PhD, University of Vienna

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Anticipated)

April 1, 2015

Study Completion (Anticipated)

April 1, 2015

Study Registration Dates

First Submitted

December 19, 2014

First Submitted That Met QC Criteria

February 19, 2015

First Posted (Estimate)

February 26, 2015

Study Record Updates

Last Update Posted (Estimate)

February 26, 2015

Last Update Submitted That Met QC Criteria

February 19, 2015

Last Verified

February 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Change of Gastric pH

Clinical Trials on water

3
Subscribe